Progetto vincitore della Borsa di Studio SISA 2017 - Polito




Evaluation of the effects of ANGPTL3 on cultured adipocytes

Luca Polito



Detection of loss-of-function (LOF) mutations in ANGPTL3 gene in humans revealed the existence of a new lipid phenotype, called familial combined hypolipidemia (FHBL2, OMIM #605019).ANGPLT3 protein is known to be involved in the inhibitory regulation of extracellular lipases (LPL and HL), so that its absence increases the lipolytic degradation of TG-rich lipoproteins (in particular VLDL) and HDL. Accordingly, the FHBL2 status is characterized by markedly reduced levels of all apoB-containing lipoproteins (VLDL and LDL) and HDL.


Interestingly, this condition is also characterized by reduced levels of circulating free fatty acids (FFA).1 This indicates that ANGPTL3 also plays a role in regulating the metabolism of FFA. The molecular mechanisms underlying this action remains unclear. As plasma FFAs are mainly derived from the lipolysis of triglycerides in adipose tissue, our primary hypothesis is that ANGPTL3 regulates lipolytic pathways in adipocytes. The molecular mechanisms underlying the effect of ANGPTL3 on lipolysis in adipose tissue remains largely unclear.


Therefore, the main aim of present study is to investigate changes in lipolytic pathways induced by the addition of ANGPTL3 to 3T3-L1 cell line, an in vitro model of mature adipocytes. Changes in release of FFA and glycerol as well as in cell expression of genes involved in the canonical and non-canonical activation of lipolytic pathways will be investigated by a combination of biochemical measures, Western blot and RT-PCR analyses.
The demonstration that ANGPTL3 influence FFA adipose tissue metabolism would expand the role of this hepatokine in lipid metabolism




Area Soci


38° Congresso Nazionale

38° Congresso Nazionale

Bologna, 1-3 dicembre 2024

[continua a leggere]

Congresso Regionale SISA Sezione Campania

Napoli, 13 Dicembre 2023

[continua a leggere]

Congresso Regionale SISA Sezione Siculo-Calabra

Catania, 3-4 Dicembre 2023

[continua a leggere]

SISA LIPID ACADEMY - Corso avanzato di lipidologia clinica

Modena, 22-23 Giugno 2023

[continua a leggere]

Giornale Italiano Arteriosclerosi

Rivista in lingua italiana
riservata ai Soci SISA
Ultimo numero:
Anno 14 • N.4/2023

[continua a leggere]

HoFH today

Rivista Italiana della
Familiare Omozigote
Anno 5 • N.1/2023

[continua a leggere]

Rivista NMCD

Nutrition, Metabolism and Cardiovascular Diseases

Istruzioni per l'accesso online

IF 2018: 3.340


EAS Lipid Clinic Webinar - Le linee guida per le dislipidemie: presente e futuro
[continua a leggere]
EAS Advanced Course in Rare Lipid Disease
[continua a leggere]


Per essere informati sulle novità di S.I.S.A. iscrivetevi alla nostra newsletter inserendo
il vostro indirizzo di posta elettronica

Progetto LIPIGEN

Nuovo sito dedicato al Progetto LIPIGEN


Progetto LIPIGEN - Vecchio portale
E' necessario essere loggati come utente
Lipigen per poter accedere alla pagina

PROject Statin Intolerance SISA


PROSISA – PROject Statin Intolerance SISA
E' necessario essere loggati come utente
PROSISA per poter accedere alla pagina

GILA - Lipoprotein Aferesi


Gruppo Interdisciplinare Lipoprotein Aferesi
(Accesso Gruppo GILA-Lipoprotein Aferesi)

E' necessario essere loggati come utente del Gruppo GILA per poter accedere


Gruppo Interdisciplinare Lipoprotein Aferesi
(Documentazione ad accesso libero)

Pagina informativa per medici e pazienti